R1881 treatment modulates LNCaP proteome.

ABSTRACT: The androgen receptor is considered as the key promoter of prostate cancer. It is a transcription factor that controls the transcription of hundreds of its target genes. In this project we focuses on how androgen receptor stimulation by the synthetic androgen R1881 can affect the proteome of peroxiosmes and the antioxidant enzymes in LNCaP cells.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell Of Prostate, Cell Culture

DISEASE(S): Prostate Adenocarcinoma

SUBMITTER: Mohamed Hussein  

LAB HEAD: Marc Fransen

PROVIDER: PXD054374 | Pride | 2024-11-01

REPOSITORIES: Pride